NXTC
Price
$11.93
Change
+$3.23 (+37.13%)
Updated
Oct 17 closing price
Capitalization
31.93M
11 days until earnings call
RANI
Price
$1.64
Change
+$1.17 (+248.94%)
Updated
Oct 17 closing price
Capitalization
78.55M
24 days until earnings call
Interact to see
Advertisement

NXTC vs RANI

Header iconNXTC vs RANI Comparison
Open Charts NXTC vs RANIBanner chart's image
NextCure
Price$11.93
Change+$3.23 (+37.13%)
Volume$439.92K
Capitalization31.93M
Rani Therapeutics Holdings
Price$1.64
Change+$1.17 (+248.94%)
Volume$492.84M
Capitalization78.55M
NXTC vs RANI Comparison Chart in %
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. RANI commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and RANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 20, 2025
Stock price -- (NXTC: $11.93 vs. RANI: $1.64)
Brand notoriety: NXTC and RANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 1434% vs. RANI: 4521%
Market capitalization -- NXTC: $31.93M vs. RANI: $78.55M
NXTC [@Biotechnology] is valued at $31.93M. RANI’s [@Biotechnology] market capitalization is $78.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileRANI’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • RANI’s FA Score: 0 green, 5 red.
According to our system of comparison, NXTC is a better buy in the long-term than RANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 3 TA indicator(s) are bullish while RANI’s TA Score has 6 bullish TA indicator(s).

  • NXTC’s TA Score: 3 bullish, 4 bearish.
  • RANI’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, RANI is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а +79.40% price change this week, while RANI (@Biotechnology) price change was +257.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

RANI is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RANI($78.6M) has a higher market cap than NXTC($31.9M). NXTC YTD gains are higher at: 28.945 vs. RANI (19.708). RANI has higher annual earnings (EBITDA): -47.11M vs. NXTC (-61.2M). NXTC has more cash in the bank: 35.3M vs. RANI (10.2M). NXTC has less debt than RANI: NXTC (4.67M) vs RANI (21.6M). RANI has higher revenues than NXTC: RANI (1.2M) vs NXTC (0).
NXTCRANINXTC / RANI
Capitalization31.9M78.6M41%
EBITDA-61.2M-47.11M130%
Gain YTD28.94519.708147%
P/E RatioN/AN/A-
Revenue01.2M-
Total Cash35.3M10.2M346%
Total Debt4.67M21.6M22%
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCRANI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 27 days ago
85%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIN58.140.93
+1.63%
Main Street Capital Corp
CRH117.460.52
+0.44%
CRH Public Limited
SMC20.03-0.14
-0.69%
Summit Midstream Corporation
SES3.07-0.07
-2.23%
SES AI Corp
RENT4.33-0.17
-3.78%
Rent the Runway

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+37.13%
CYTK - NXTC
37%
Loosely correlated
-0.88%
ORMP - NXTC
33%
Poorly correlated
-1.76%
GOSS - NXTC
32%
Poorly correlated
-5.19%
PRAX - NXTC
32%
Poorly correlated
+16.77%
RANI - NXTC
32%
Poorly correlated
+248.27%
More

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KZR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
+248.27%
KZR - RANI
55%
Loosely correlated
+52.52%
ARTV - RANI
48%
Loosely correlated
+116.97%
IRON - RANI
39%
Loosely correlated
+20.95%
ADVM - RANI
32%
Poorly correlated
-5.92%
VYGR - RANI
32%
Poorly correlated
-7.13%
More